Regenerative Medical Technology (RMTG) EBT (2018 - 2026)
Regenerative Medical Technology (RMTG) posted quarterly EBT of -$2.0 million for Q1 2026, down 157.69% year-over-year from $3.4 million in Q1 2025, and up 15.26% quarter-over-quarter from -$2.3 million in Q4 2025.
Regenerative Medical Technology (RMTG) EBT (2018 - 2026) Analysis & Trends
Regenerative Medical Technology's EBT history runs 9 years deep, the most recent figure standing at -$2.0 million for Q1 2026.
- In Q1 2026, EBT fell 157.69% year-over-year to -$2.0 million; the TTM figure through Mar 2026 stood at -$9.5 million (down 118.19% YoY), while the FY2025 annual figure was -$8.6 million, down 44.8% from the prior year.
- EBT for Q1 2026 stood at -$2.0 million, up from -$2.3 million in the prior quarter.
- The five-year high for EBT was $4.7 million in Q4 2023, with the low at -$3.9 million in Q3 2025.
- The 5-year median for EBT is -$1.5 million (2022), against an average of -$1.2 million.
- The sharpest annual moves came in 2023 and 2024: EBT soared 292.21% in 2023, then sank 378.81% in 2024.
- Regenerative Medical Technology's EBT stood at -$2.5 million in 2022, then jumped by 292.21% to $4.7 million in 2023, then plunged by 113.53% to -$639071.0 in 2024, then plunged by 262.07% to -$2.3 million in 2025, then grew by 15.26% to -$2.0 million in 2026.
- Business Quant data shows RMTG's EBT at -$2.0 million in Q1 2026, -$2.3 million in Q4 2025, and -$3.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.79 Bn | 131.94 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 86.74 Bn | 78.74 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 65.48 Bn | 60.29 Bn | 1.37 Bn | 541.00 Mn |
| 4 | Moderna | 59.32 Bn | 54.18 Bn | 52.00 Mn | -767.00 Mn |
| 5 | BeOne Medicines | 42.08 Bn | 36.98 Bn | 1.53 Bn | 312.46 Mn |
| 6 | Alnylam Pharmaceuticals | 31.81 Bn | 28.50 Bn | 992.69 Mn | 177.81 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -264.70 Mn |
| 8 | Insmed | 27.56 Bn | 26.40 Bn | 358.27 Mn | -11.37 Mn |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | 81.49 Mn |
| 10 | Regenerative Medical Technology | 814,616.00 | -246,832.00 | 1.77 Mn | -1.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.96 Mn |
| Dec 31, 2025 | -2.31 Mn |
| Sep 30, 2025 | -3.94 Mn |
| Jun 30, 2025 | -1.31 Mn |
| Mar 31, 2025 | -760,890.00 |
| Dec 31, 2024 | -639,071.00 |
| Sep 30, 2024 | -885,924.00 |
| Jun 30, 2024 | -2.08 Mn |
| Mar 31, 2024 | -1.96 Mn |
| Dec 31, 2023 | 4.72 Mn |
| Sep 30, 2023 | -1.73 Mn |
| Jun 30, 2023 | -433,555.00 |
| Mar 31, 2023 | -577,763.00 |
| Dec 31, 2022 | -2.46 Mn |
| Sep 30, 2022 | -1.34 Mn |
| Jun 30, 2022 | -1.50 Mn |
| Mar 31, 2022 | -1.68 Mn |
| Dec 31, 2021 | 1.16 Mn |
| Sep 30, 2021 | -9.92 Mn |
| Jun 30, 2021 | -694,968.00 |